Skip NavigationSkip to Content

E-Combretastatin and E-resveratrol structural modifications: Antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes

  1. Author:
    Pettit, R. K.
    Pettit, G. R.
    Hamel, E.
    Hogan, F.
    Moser, B. R.
    Wolf, S.
    Pon, S.
    Chapuis, J. C.
    Schmidt, J. M.
  2. Author Address

    Pettit, Robin K.; Pettit, George R.; Hogan, Fiona, Wolf, Sonja, Pon, Sandy, Chapuis, Jean-Charles, Schmidt, Jean M.] Arizona State Univ, Canc Res Inst, Tempe, AZ 85287 USA. [Pettit, Robin K.; Pettit, George R.; Hogan, Fiona, Wolf, Sonja, Pon, Sandy, Chapuis, Jean-Charles, Schmidt, Jean M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA. [Hamel, Ernest] NCI, Toxicol & Pharmacol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA. [Moser, Bryan R.] ARS, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.
    1. Year: 2009
  1. Journal: Bioorganic & Medicinal Chemistry
    1. 17
    2. 18
    3. Pages: 6606-6612
  2. Type of Article: Article
  1. Abstract:

    As part of a broad-based SAR investigation of E-resveratrol (strong sirtuin activator and antineoplastic) and the anticancer vascular-targeting combretastatin-type stilbenes, a series of twenty-three beta-E-nitrostyrenes was synthesized in order to evaluate potential antineoplastic, antitubulin, and antimicrobial activities. The beta-E-nitrostyrenes evaluated ranged from monosubstituted phenols to trimethoxy and 3-methoxy- 4,5-methylenedioxy derivatives. Two of the beta-nitrostyrenes were synthesized as water-soluble sodium phosphate derivatives (4t, 4v). All except four (4r, 4s, 4t, 4u) of the series significantly inhibited a minipanel of human cancer cell lines. All but eight led to an IC50 of < 10 mu M for inhibition of tubulin polymerization, and all except three (4l, 4t, 4v) displayed antimicrobial activity. (C) 2009 Published by Elsevier Ltd.

    See More

External Sources

  1. DOI: 10.1016/j.bmc.2009.07.076
  2. PMID: 19709889

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel